Search clinical trials for: 40% N2O

Total 7825 results

Duke University
American Heart Association

Terminated

Pacing Affects Cardiovascular Endpoints in Patients With Right Bundle-Branch Block (The PACE-RBBB Trial) (PACE-RBBB)

Heart Failure | Right Bundle-Branch Block

United States
University of Chicago
National Institute on Drug Abuse (NIDA)

Completed

Lack of Acute Tolerance Development to Effects of Nitrous Oxide - 4

Substance-Related Disorders | Opioid-Related Disorders

United States
The Queen Elizabeth Hospital

Completed

Safety of Continuous Potassium Chloride Infusion in Critical Care (ASPIC)

Arrhythmias, Cardiac | Hypokalemia

Australia
University of Chicago
National Institute on Drug Abuse (NIDA)

Completed

Effects of Nitrous Oxide: A Dose-Response Analysis - 5

Substance-Related Disorders | Opioid-Related Disorders

United States
University of Chicago
National Institute on Drug Abuse (NIDA)

Completed

Reinforcing Effects of Brief Exposures to Nitrous Oxide - 8

Substance-Related Disorders | Opioid-Related Disorders

United States
Region Örebro County

Not yet recruiting

Regional Distribution of Ventilation at Different Respiratory Rates

Mechanical Ventilation | Atelectasis | Distribution of Ventilation
University of Chicago
National Institute on Drug Abuse (NIDA)

Completed

Effects of Alcohol History on Effects of Nitrous Oxide - 9

Substance-Related Disorders | Alcohol-Related Disorders | Opioid-Related Disorders

United States
Yonsei University

Unknown

Influence of Central Sensitization on Efficacy of Patient-controlled Epidural Analgesia in Osteoarthritis Patients Undergoing Total Knee Replacement

Knee Osteoarthritis

Korea, Republic of
Pontificia Universidad Catolica de Chile

Completed

Analyze Changes in Respiratory Rate When Using the Scare Respirator (RESPSUS)

Preterm Labor | Apnea of Newborn

Chile
Breas Medical S.A.R.L.

Withdrawn

Target Volume Mode Controlled Ventilator in Obesity Hypoventilation Syndrome (OVO)

Obesity Hypoventilation Syndrome

France
University of Chicago
National Institute on Drug Abuse (NIDA)

Completed

Effects of Subanesthetic Concentrations of Nitrous Oxide - 1

Substance-Related Disorders | Opioid-Related Disorders

United States
University of Zurich

Completed

Effects of Chocolate in Patients With Chronic Heart Failure

Heart Failure

Switzerland
Johns Hopkins University
National Institute on Aging (NIA)

Active, not recruiting

Sound and Music for Mild Cognitive Impairment

Mild Cognitive Impairment

United States
Zhongshan Ophthalmic Center, Sun Yat-sen University

Unknown

Development of the Glaucoma Visual Functioning Questionnaire-40 and Its Psychometric Properties

Primary Glaucoma | Glaucoma Suspect

China
Merck Sharp & Dohme LLC

Completed

Dose-Ranging Study of Quadrivalent Human Papillomavirus (HPV) (Types 6,11,16,18) L1 Virus-Like Particle (VLP) Vaccine (V501-007)(COMPLETED)

Papillomavirus Infections | Genital Diseases, Female
University of Chicago
National Institute on Drug Abuse (NIDA)

Completed

Cold Water Immersion Modulates Reinforcing Effects of Nitrous Oxide - 2

Substance-Related Disorders | Opioid-Related Disorders

United States
Grupo Español de Tumores Huérfanos e Infrecuentes
Astellas Pharma Inc; Apices Soluciones S.L.

Completed

Enzalutamide in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors: GREKO III Study (GREKO III)

Ovarian Cancer

Spain
US Department of Veterans Affairs
Abbott Diagnostics Division; Pan American Laboratories

Completed

Homocysteine Study (HOST)

Renal Failure | End Stage Renal Disease

United States, Puerto Rico
Betsi Cadwaladr University Health Board
Oxford Brookes University

Recruiting

Physical Activity a Vital Sign? 40 Steps to Safety Test for Patients With COVID-19

Covid19 | Medical Emergencies

United Kingdom
Duke University

Completed

Breakfast Nutrition and Inpatient Glycemia

Hyperglycemia | Cardiovascular Disease | Diabetes, Type 2 | Diabetes, Type 1

United States
UroGen Pharma Ltd.

Completed

Pilot Study to Evaluate the Clinical Response to Mitomycin-C in Hydrogel (TC-3) Administered Intravesically in NMIBC Patients

Neoplasms | Urologic Neoplasms | Urologic Diseases | Urinary Bladder Diseases | Urinary Bladder Neoplasms

India
Zhongda Hospital
Sun Yat-sen University; Jiangsu Cancer Institute & Hospital; Zhejiang University and other collaborators

Not yet recruiting

A Real World Study of Regogfinib in HCC

Hepatocellular Carcinoma
Aarhus University Hospital
Odense University Hospital; Zealand University Hospital; Rigshospitalet, Denmark and other collaborators

Completed

Reducing Atrial Pacing Rate to Reduce Atrial Fibrillation in Patients With Sick Sinus Syndrome. (DANPACEII)

Atrial Fibrillation | Sinus Node Disease

Denmark
Boston Children's Hospital

Completed

Efficacy and Safety of a Lung Recruitment Protocol in Children With Acute Lung Injury (Recruitment)

Acute Respiratory Distress Syndrome | Acute Lung Injury

United States
Société des Produits Nestlé (SPN)

Completed

To Evaluate the Post-Prandial Metabolic Effects of Oligomalt in Adults With T2D and in HAO (LORIS-02)

Dietary Supplement

United States
Menarini Group
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company

Completed

Olmesartan/HCTZ 40/12.5 mg Combination Therapy Versus Olmesartan Medoxomil 40 mg Monotherapy in Essential Hypertension

Hypertension

Poland, Germany, Israel, Romania, Italy, Denmark, Czechia, Croatia
Sandoz

Completed

Phase III Study Assessing the Efficacy, Safety and Immunogenicity of SOK583A1 Versus Eylea® in Patients With Neovascular Age-related Macular Degeneration (Mylight)

Neovascular Age-related Macular Degeneration

United States, Bulgaria, Czechia, Australia, Austria, France, Germany, Hungary, Israel, Japan, Latvia, Lithuania, Poland, Portugal, Slovakia, Spain
University of Michigan
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...

Completed

Parameters of Exercise to Prevent Osteoporosis (OSTEOPOROSISEX)

Osteoporosis, Postmenopausal

United States
Genencell Co. Ltd.

Recruiting

Efficacy and Safety of ES16001 in Patients With COVID-19

COVID-19

Korea, Republic of
Humanitas Clinical and Research Center

Unknown

Radial Versus Femoral Access for Superselective Embolization of Hepatocellular Carcinoma

Hepatocellular Carcinoma | Hepatocellular Carcinoma Non-resectable

Italy
Institute of Cancer Research, United Kingdom
AstraZeneca; Astellas Pharma Inc; Prostate Cancer UK

Terminated

Combination Study of AZD5069 and Enzalutamide. (ACE)

Metastatic Castration Resistant Prostate Cancer

United Kingdom, Switzerland
Idorsia Pharmaceuticals Ltd.

Completed

A Study to Investigate the Pharmacokinetics of ACT-1014-6470 in Subjects With Severe Renal Impairment Compared to Control Subjects

Healthy

Germany
University Hospital, Basel, Switzerland

Completed

Perianal Nerval Block in Proctological Interventions

Hemorrhoids | Perianal Fistula | Fissure in Ano

Switzerland
Bioniz Therapeutics

Completed

A Dose-Ranging Study of IV BNZ-1 in LGL Leukemia or Refractory CTCL

LGL Leukemia | CTCL

United States
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Completed

First-in-Human Study of the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Profile of VX-984 in Combination With Chemotherapy

Advanced Solid Tumor

United States
Bakirkoy Dr. Sadi Konuk Research and Training Hospital

Completed

New Cross Linked Hyaluronan Gel After Deep Infiltrating Endometriosis Surgery (HYALOENDOQoL)

Quality of Life | Endometriosis | Surgery | Adhesion
Novo Nordisk A/S

Completed

A Research Study Comparing Blood Levels of Medicines NNC0194-0499 and Semaglutide Administered as a Combination Formulation Versus Two Separate Formulations

Non-alcoholic Steatohepatitis

Canada
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Relative Oral Bioavailability of Seltorexant (JNJ-42847922) After Administration of 3 Different Formulations in Healthy Participants Under Fasted and Semi-fasted Conditions

Healthy

United States
Bioniz Therapeutics
Celerion

Completed

A Multiple-Dose Study of Intravenous BNZ132-1-40 in Healthy Adult Subjects

Safety and Tolerability in Healthy Subjects

United States
George Papanicolaou Hospital

Unknown

Acute Effects of Oxygen Supplementation Among IPF Patients

Idiopathic Pulmonary Fibrosis

Greece
HealOr

Unknown

Safety and Efficacy Study of HO/03/03 10-40 Micro Grams to Treat Hard to Heal Wounds (H2H)

Hard to Heal Wounds

Israel
Istituto Oncologico Veneto IRCCS

Completed

Regorafenib in Patients With Relapsed Glioblastoma. IOV-GB-1-2020 REGOMA-OSS

Glioblastoma Multiforme

Italy
Janssen Research & Development, LLC

Completed

A Study to Assess the Effect of Seltorexant Compared to Placebo on Respiration During Sleep in Adult Participants With Obstructive Sleep Apnea

Sleep Apnea, Obstructive

United States
USDA Grand Forks Human Nutrition Research Center

Completed

The Breathe Light Study

Obesity | Over-eating

United States
Kangbuk Samsung Hospital

Completed

Pulmonary Recruitment Maneuver for Postlaparoscopic Shoulder Pain

Gynecologic Diseases

Korea, Republic of
Abbott

Completed

Remission in Subjects With Crohn's Disease, 1 Year Phase (CLASSICII)

Crohn's Disease

United States
Mylan Pharmaceuticals Inc
MEDA Pharma GmbH & Co. KG; Mylan Inc.; IQVIA Pvt. Ltd

Completed

Hulio Interchangeability to Humira®, Comparing Pharmacokinetics, Efficacy, Safety and Immunogenicity

Moderate Chronic Plaque Psoriasis | Severe Chronic Plaque Psoriasis

Bulgaria, Czechia, Estonia, Poland
Erasmus Medical Center

Enrolling by invitation

Explorative Study to Investigate the Acid-base Response to Sodium and Potassium Salts in Patients With Chronic Kidney Disease. (5S)

CKD | Electrolyte and Fluid Balance Conditions | Metabolic Acidosis

Netherlands
Federal University of Minas Gerais

Completed

Music Distraction Strategy in Children Dental Care

Children Behavior
Liegang Liu

Completed

Association of β-amyloid 40 and 42 With Prediabetes

PreDiabetes

Search clinical trials for: 40% N2O

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Pakistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations